Natural language processing system identifies care quality through EHRs

Researchers have developed a natural language processing (NLP) system capable of measuring the quality of heart failure inpatient care by analyzing data collected from electronic health records (EHRs), according to a study published in JMIR Medical Informatics.

Developed with the aim to accurately automate quality measures for patients with heart failure within the U.S. Department of Veterans Affairs (VA), the NLP Congestive Heart Failure Information Extraction Framework (CHIEF) identified heart failure patients with left ventricular ejection fraction (LVEF) less than 40 percent and where an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker was prescribed when patients were discharged.

“Congestive heart failure is a prevalent condition and CHIEF is an application that could provide an automated first review for heart failure patients to assess guideline-concordant care,” wrote first author Jennifer Hornung Garvin, MBA, PhD and colleagues.

In this study, researchers collected data from 1,083 inpatients form eight VA medical centers to train and test CHIEF. Additionally, 15 interviews were conducted for stakeholder feedback on whether the system could be implemented elsewhere.

Results showed CHIEF classified hospitalizations with 98.9 percent sensitivity and a positive prediction at 98.7 percent, in increase from the sensitivity and reference standard of 98.5 percent for External Peer Review Program evaluations. Additionally, the system was able identify mentions and values of LVEF and medications with high to fair recall. Medications were examined with recall at 97.8 to 99.7 percent and precision at 96 to 97.8 percent. Mentions of LVEF were examined with recall at 97.8 to 98.6 percent and precision of 98.6 to 99.4 percent.

“Our results demonstrate that automated methods using NLP can improve the efficiency and accuracy of data collection and facilitate more complete and timely data capture at the time of discharge, at a potentially reduced cost,” concluded Hornung and colleagues. “The next step is to transform health care big data into actionable knowledge for quality improvement and research that helps to improve patient care, and potentially limit health care costs, with the aim of developing infrastructure with real-time data to support decision making.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.